Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SREBF1 inhibitors(Sterol regulatory element binding transcription factor 1 inhibitors), SREBP-2 inhibitors(Sterol regulatory element-binding protein 2 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H19N3O2S2 |
InChIKeyOWAXXHRQPWGNTG-UHFFFAOYSA-N |
CAS Registry1046045-61-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic Diseases | Preclinical | US | - | |
Neoplasms | Preclinical | US | - | |
Nonalcoholic Steatohepatitis | Preclinical | US | - | |
Obesity | Preclinical | US | - |